The latest gynaecological cancer news
Risks of removing ovaries at benign hysterectomy may outweigh the benefits for women at low risk for ovarian cancer
An emulated target trial of more than 140,000 women in Denmark found that removing the…
Browsing: Gynaecologic Cancers
International clinical trial conducts head-to-head comparison of open versus minimally invasive surgery for early-stage cervical cancer
Gynecologic surgeons with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and…
Researchers present a new approach to the treatment of ovarian cancer using RNA-based nanodrugs
In a study conducted at Tel Aviv University the protein CKAP5 (cytoskeleton-associated protein) was used…
AACR 2023: Researchers report results in rare gynaecologic cancers from DART immunotherapy trial
Results from the S1609 DART clinical trial, which tested an immunotherapy combination of ipilimumab plus…
ANZGOG 2023 ASM Review by Dr Michelle Wilson
Written by Dr Michelle Wilson, Medical Oncologist & ANZGOG New Zealand Director Introduction The Australia…
Cervical cancer can be beaten – the key is vaccinating young girls
Lynette Denny, University of Cape Town In 2020 the World Health Organization introduced a plan…
Candidate cervical cancer drugs quickly evaluated using new model
Researchers at Oregon State University, USA, have created a means of speeding up and improving…
Understanding why BRCA2 is linked to cancer risk
New study shows exactly how the gene BRCA2, linked to susceptibility to breast and ovarian…
FDA grants regular approval to dostarlimab-gxly for dMMR endometrial cancer
On February 9, 2023, the Food and Drug Administration (FDA) approved dostarlimab-gxly for adult patients with…
Chemotherapy-resistant ovarian cancer cells protect their neighbours
Certain chemotherapy-resistant ovarian cancer cells protect neighbouring cancer cells by sending signals that induce resistance,…